Drugs that contain Desloratadine
1. Clarinex patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7214684 | ORGANON | Methods for the treatment of allergic rhinitis |
Dec, 2014
(9 years ago) | |
| US7211582 | ORGANON | Methods for treating urticaria using descarboethoxyloratadine |
Dec, 2014
(9 years ago) | |
| US7214683 | ORGANON | Compositions of descarboethoxyloratadine |
Dec, 2014
(9 years ago) | |
| US5607697 | ORGANON | Taste masking microparticles for oral dosage forms |
Jun, 2015
(8 years ago) | |
|
US7211582 (Pediatric) | ORGANON | Methods for treating urticaria using descarboethoxyloratadine |
Jun, 2015
(8 years ago) | |
|
US7214683 (Pediatric) | ORGANON | Compositions of descarboethoxyloratadine |
Jun, 2015
(8 years ago) | |
|
US7214684 (Pediatric) | ORGANON | Methods for the treatment of allergic rhinitis |
Jun, 2015
(8 years ago) | |
|
US5607697 (Pediatric) | ORGANON | Taste masking microparticles for oral dosage forms |
Dec, 2015
(8 years ago) | |
| US6100274 | ORGANON | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jul, 2019
(4 years ago) | |
| US7405223 | ORGANON | Treating allergic and inflammatory conditions |
Jul, 2019
(4 years ago) | |
|
US6100274 (Pediatric) | ORGANON | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
Jan, 2020
(4 years ago) | |
|
US7405223 (Pediatric) | ORGANON | Treating allergic and inflammatory conditions |
Jan, 2020
(4 years ago) | |
| US7618649 | ORGANON | Extended release oral dosage composition |
Dec, 2020
(3 years ago) | |
|
US7618649 (Pediatric) | ORGANON | Extended release oral dosage composition |
Jun, 2021
(2 years ago) | |
Market Authorisation Date: 14 July, 2005
Treatment: Treatment of allergic rhinitis; Treatment of chronic idiopathic urticaria; Administering desloratadine to treat the symptoms of perennial allergic rhinitis, seasonal allergic rhinitis, or chronic idio...
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL; TABLET;ORAL
CLARINEX family patents
2. Clarinex patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7214684 | MERCK SHARP DOHME | Methods for the treatment of allergic rhinitis |
Dec, 2014
(9 years ago) | |
| US7214683 | MERCK SHARP DOHME | Compositions of descarboethoxyloratadine |
Dec, 2014
(9 years ago) | |
| US7211582 | MERCK SHARP DOHME | Methods for treating urticaria using descarboethoxyloratadine |
Dec, 2014
(9 years ago) | |
|
US7214684 (Pediatric) | MERCK SHARP DOHME | Methods for the treatment of allergic rhinitis |
Jun, 2015
(8 years ago) | |
|
US7214683 (Pediatric) | MERCK SHARP DOHME | Compositions of descarboethoxyloratadine |
Jun, 2015
(8 years ago) | |
|
US7211582 (Pediatric) | MERCK SHARP DOHME | Methods for treating urticaria using descarboethoxyloratadine |
Jun, 2015
(8 years ago) | |
| US6514520 | MERCK SHARP DOHME | Stabilized antihistamine syrup |
Jun, 2018
(5 years ago) | |
|
US6514520 (Pediatric) | MERCK SHARP DOHME | Stabilized antihistamine syrup |
Dec, 2018
(5 years ago) | |
Market Authorisation Date: 01 September, 2004
Treatment: Treatment of allergic rhinitis; Treatment of chronic idiopathic urticaria
Dosage: SOLUTION;ORAL
CLARINEX family patents